Masi Dina 4
4 · INTEGRATED BIOPHARMA INC · Filed May 22, 2025
Insider Transaction Report
Form 4
Masi Dina
Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-21$0.09/sh+135,000$12,150→ 347,200 total - Disposition to Issuer
Stock Option (right to buy)
2025-05-21−135,000→ 0 totalExercise: $0.09Exp: 2025-06-02→ Common Stock (135,000 underlying)
Footnotes (2)
- [F1]135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
- [F2]72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.